European review for medical and pharmacological sciences · 2014
Efficacy of Tiopronin in treatment of severe non-alcoholic fatty liver disease.
СтатьяПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Tang M-C, Cheng L, Qiu L, Jia R-G, Sun R-Q, Wang X-P, Hu G-Y, Zhao Y
Аннотация
INTRODUCTION: The D antigen is highly immunogenic, and alloanti-D antibodies in maternal blood may cause haemolytic disease of the foetus and newborn. Prophylactic administration of anti-D immunoglobulin (Ig) to D-negative pregnant women significantly reduces the risk of alloimmunisation. However, absorption after intramuscular (IM) injection may be impaired in obese women.
CASE DESCRIPTION: We report the case of a 27-year-old D-negative pregnant woman body mass index (BMI) 35 kg/m2 who received three IM injections of anti-D Ig during pregnancy and after caesarean section. Despite confirmed administration, her indirect antiglobulin tests (IATs) remained negative or only borderline positive. Investigations excluded weak/partial D variants, foetomaternal haemorrhage, chimerism, and other causes. Due to her high BMI, we hypothesised that the injections were administered into subcutaneous fat, resulting in minimal absorption. After intravenous administration of anti-D Ig, the IAT became strongly positive, confirming correct drug delivery.
CONCLUSION: This case highlights the importance of considering maternal BMI in the administration of anti-D Ig. In obese women, inadequate IM administration may compromise prophylaxis. Intravenous administration or the use of alternative injection sites should be considered.
LEARNING POINTS: Subcutaneous tissue thickness plays a crucial role in the absorption of intramuscular anti-D immunoglobulin.Women with high body mass index are at risk of inadequate intramuscular administration, which may result in subtherapeutic serum anti-D levels.The intravenous route or careful selection of injection site (e.g., deltoid) should be considered in obese patients.
CASE DESCRIPTION: We report the case of a 27-year-old D-negative pregnant woman body mass index (BMI) 35 kg/m2 who received three IM injections of anti-D Ig during pregnancy and after caesarean section. Despite confirmed administration, her indirect antiglobulin tests (IATs) remained negative or only borderline positive. Investigations excluded weak/partial D variants, foetomaternal haemorrhage, chimerism, and other causes. Due to her high BMI, we hypothesised that the injections were administered into subcutaneous fat, resulting in minimal absorption. After intravenous administration of anti-D Ig, the IAT became strongly positive, confirming correct drug delivery.
CONCLUSION: This case highlights the importance of considering maternal BMI in the administration of anti-D Ig. In obese women, inadequate IM administration may compromise prophylaxis. Intravenous administration or the use of alternative injection sites should be considered.
LEARNING POINTS: Subcutaneous tissue thickness plays a crucial role in the absorption of intramuscular anti-D immunoglobulin.Women with high body mass index are at risk of inadequate intramuscular administration, which may result in subtherapeutic serum anti-D levels.The intravenous route or careful selection of injection site (e.g., deltoid) should be considered in obese patients.